mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Blind subxiphoid pericardiotomy to relieve critical acute hemopericardium

Kurimoto Y et al. – Blind subxiphoid pericardiotomy (BSP) was safe and effective for cardiac tamponade due to acute hemopericardium. Critical complications during percutaneous catheter drainage (PCD) for hemopericardium could not be avoided in some cases because of clots in the pericardium.

Methods
  • The authors designed a prospective observational study to evaluate blind subxiphoid pericardiotomy (BSP) for critical cardiac tamponade due to hemopericardium.
  • Emergency patients (n=148) with acute hemopericardium secondary to trauma (n=12), acute aortic disease (n=122), or cardiac rupture following acute myocardial infarction (n=14) were the subjects.
  • Early results were compared between the BSP group (n=53) and the PCD group (n=95).

Results
  • BSP was effective at relieving cardiac tamponade in all 53 cases, but PCD was ineffective in 12 cases (12.6 %, p=0.008).
  • Procedure–related complication rates of BSP and PCD were 0 and 16.8 %, respectively (p=0.002).
  • Survival rates for the BSP and PCD groups were 18.9 and 6.3 %, respectively (p=0.018).
  • Since 2005, when the authors discarded the restriction that only board–certified surgeons should perform BSP, acute care physicians (including trainees) have performed BSP for 22 patients without procedure–related complications.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close